Targeted PEGylated PLGA Nanoparticles Enhance Hesperidin Delivery in Ovarian Cancer
Hesperidin-loaded PEGylated PLGA nanoparticles demonstrate improved dissolution and cytotoxicity in EOC models.
Asset / Drug
Drug and asset intelligence for Hesperidin with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.